TrialNature medicine2022

Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results.

Christine D Palmer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.